Rowan Wick’s first season with the Giants never got off the ground, but his future with the club is still on the table.
The veteran right-hander spent all of 2026 on the 60-day injured list after signing with San Francisco in spring training while he was still recovering from Tommy John surgery. That operation came in November of 2025, so by the time spring training arrives he should be roughly 18 months out from the procedure. Barring any setbacks - and assuming the season begins on time, which the source notes is itself a flawed assumption - he ought to be fully recovered by then.
Even though he never threw a pitch for the Giants, Wick still leaves them with a roster call this offseason. His contract includes a club option for 2027 worth $800,000. If San Francisco turns that down, he would go through arbitration, where MLB Trade Rumors projects he would also earn $800,000.
That creates a pretty unusual spot for the Giants. The money is essentially the same either way, but the organization still has to decide whether to keep him on the roster next season. And if they decline the option, they could still non-tender him and make him a free agent.
The timing only adds to the mess. Once the World Series ends, the Giants will need to sort through a roster crunch, and Wick is one of 17 players currently on the 60-day injured list. Since that injured list disappears in the offseason, those players will have to be activated or put on waivers.
San Francisco likely didn’t sign Wick simply to stash him and move on, especially since he was still viewed as a useful arm when healthy. In parts of five major league seasons, he put up a 3.82 ERA, 3.49 FIP, 1.43 WHIP, 9.9 K/9, and a 2.42 SO/W rate. Four of those seasons came with the Chicago Cubs, and he has not pitched in a big league game since 2022.
In Other News...
Giants Still Have One Roster Problem They Cant Ignore Before 2027
Buster Poseys front-office overhaul has given the Giants a different feel heading into the 2026 season, with Tony Vitello stepping in as manager and the organization trying to pull itself out of a long stretch of inconsistency since the 2014 title. The club has made the postseason only twice in that span, and the current roster still carries obvious work to do after a season that exposed needs across the bullpen, the rotation and the lineup.
San Francisco is banking on a few core pieces to help turn the corner, with Camilo Doval still a key arm in relief and Rafael Devers and Bryce Eldridge among the bats expected to matter in the near future. Even so, the biggest question is whether the Giants can solve the lingering roster flaw that continues to hang over the franchise as it looks past 2026 and toward a more complete team in 2027. [Read more 🡒]
Giants Still Have A 2027 Bullpen Question Despite Randy Rodrguezs Return
Randy Rodrguez has started to show encouraging signs in the Arizona Fall League after working his way back from injury, and that alone gives the Giants a useful piece to monitor as they look ahead. His stuff still makes him an intriguing arm for a bullpen that will need depth and quality, and his return gives San Francisco a chance to imagine how he might fit into the mix once hes fully back in a big league setting.
Even so, the longer view matters here, especially with his earlier struggles in the closer role and the reality of a Tommy John surgery in the recent past. For the Giants, the cleaner path for 2027 is to add a dedicated closer over the offseason and let Rodrguez ease back into lower-pressure middle relief work first, rather than asking him to immediately anchor the end of games. [Read more 🡒]
Camilo Doval Just Gave Giants Fans A Real Bullpen Debate
Camilo Dovals winding 2026 season ended where so much of his early career was defined, back in a Giants uniform. After getting dealt from San Francisco to the Yankees and then to the Pirates before returning late in the year, Doval finished with two scoreless innings in his final appearances for the club, giving the Giants at least one more look at a familiar arm before the offseason arrived.
Now the front office has a choice to make, and it is not a small one for a bullpen that always seems to be under a microscope in San Francisco. The Giants must decide whether to offer Doval a contract or non-tender him, while also weighing what his place might be in the 2027 relief mix if he stays in the organization. [Read more 🡒]